Clinical Trial: Homologous Re-infection With Dengue 1 or Dengue 3

Study Status: RECRUITING
Recruit Status: RECRUITING
Study Type: INTERVENTIONAL



Official Title: Phase One, Open Label, Homologous Reinfection With Dengue-1-Virus-Live Virus Human Challenge - (DENV-1-LVHC) or Dengue-3-Virus-Live Virus Human Challenge (DENV-3-LVHC) Virus Strains

Brief Summary:

Previous studies with one dengue infection in a controlled environment at Upstate generated data that has been important in understanding the clinical signs and symptoms and how a person's body reacts to dengue infection over time.
This has helped investigators compare what is seen in the clinic to what is seen in areas where dengue is prevalent.
The investigators want to collect similar information when a person gets the same dengue twice in a controlled environment with the hope that this will lead them to a better understanding of the disease.

New participants

  • will receive one inoculation of dengue and then return to the clinic or be contacted by phone over 6 months;
  • will receive a second inoculation after 6 months and return to the clinic or be contacted by phone for three more months;
  • will collect saliva at home;
  • will allow the study team to collect blood and saliva at the clinic visits.

Participants who have been in previous dengue inoculation studies at SUNY Upstate

  • will receive one inoculation of dengue and then return to the clinic or be contacted by phone over 6 months;
  • will collect saliva at home;
  • will allow the study team to collect blood and saliva at the clinic visits.

All participants will be seen in the clinic every other day for the first three weeks after any inoculation.